This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo
C3_RESPIRATORY_INTRATHORACIC3_NAS_WIDE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
121 |
4. Check minimum number of eventsNone |
121 |
5. Include endpointsNone |
121 |
6. Filter based on genotype QC (FinnGen only) |
107 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 107 | 32 | 75 |
| Unadjusted period prevalence (%) | 0.03 | 0.01 | 0.03 |
| Median age at first event (years) | 69.74 | 64.42 | 72.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 112
- Matched controls
- 1120
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
+∞
62.5
54
*
130
Kela drug reimbursment
Malignant tumour
+∞
44.8
40
*
C39.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs
+∞
35.3
32
*
H02AB02
ATC
dexamethasone; systemic
465.0
35.0
33
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
12.1
30.6
37
44
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
20.4
19
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.3
18.4
33
61
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
18.2
17
*
C39.0
ICD-10 Finland
Malignant neoplasm: Upper respiratory tract, part unspecified
+∞
18.2
17
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.6
18.1
37
78
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
28.5
17.3
23
10
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
16.0
15
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
34.3
15.8
20
7
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
14.9
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.9
14
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
14.9
14
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
13.8
13
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
13.8
13
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
12.7
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.7
12
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.7
12
*
N02AA05
ATC
oxycodone; systemic
4.8
12.6
36
100
A04AA01
ATC
ondansetron; systemic, rectal
26.3
12.0
16
7
116
Kela drug reimbursment
Prostate cancer
+∞
11.7
11
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
13.2
11.1
19
17
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
10.6
10
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
10.6
10
*
8000/3-C39.9
ICD-O-3
Neoplasm, malignant of ill-defined sites within respiratory system
+∞
10.6
10
*
JN4BD
NOMESCO Finland
Extensive body CT
11.0
9.7
18
19
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
108.8
9.6
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.5
9
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
9.5
9
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
9.5
9
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
12.2
8.6
15
14
WF049
NOMESCO Finland
Radiotherapy of metastasis
97.1
8.5
9
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
8.4
8
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
8.4
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.2
7.8
14
14
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.4
7
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
7.4
7
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
7.4
7
*
Z51.5
ICD-10 Finland
Palliative care
6.1
6.8
18
34
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
6.3
6
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
GDC00
NOMESCO Finland
Lobectomy of lung
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
10
6
18.10
6.88
1.5
1.7
90.11
13.41
ug/l
—
10
6
43
689
0.39
5.48
5.2
5.6
5.74
6.13
mmol/l
1.94
37
609
9
264
0.28
4.19
1.1
2.0
1.08
1.28
mmol/l
—
9
215
8
10
8.51
4.13
1.0
1.0
—
—
—
0
0
33
554
0.43
4.09
3.8
4.1
15.04
14.92
pmol/l
0.10
33
484
51
708
0.49
3.44
31.2
16.0
35.47
25.89
mg/l
1.25
46
591
11
28
4.24
3.39
1.8
4.1
—
—
—
0
0
21
395
0.42
3.20
1.9
2.3
91.30
91.38
pmol/l
—
10
209
8
16
5.29
3.11
2.5
1.2
75.88
74.53
u/ml
—
8
16
5
5
10.38
3.00
1.0
1.2
13.20
20.40
u/l
—
5
5
5
6
8.64
2.77
1.2
1.2
9.40
8.17
u/l
—
5
6
26
426
0.49
2.57
4.0
3.2
52.15
49.61
u/l
0.08
26
391
38
549
0.53
2.50
34.3
20.0
14.30
13.84
%
1.22
38
537
5
8
6.48
2.39
1.4
1.1
156.24
61.68
pmol/l
—
5
8
12
47
2.74
2.36
17.3
8.7
0.52
0.72
%
1.22
12
47
19
337
0.47
2.31
7.8
4.6
3.14
2.41
ug/l
0.45
19
292
20
345
0.49
2.23
3.1
2.5
—
—
—
0
0
12
49
2.62
2.19
17.1
8.5
0.93
1.30
%
1.52
12
49
22
119
2.06
2.16
3.8
1.9
0.79
0.83
mmol/l
0.96
22
111
7
20
3.66
2.09
1.3
1.4
—
—
—
0
0
25
394
0.53
2.07
5.8
3.8
0.00
0.00
estimate
—
5
81
25
388
0.54
1.94
5.8
3.8
0.00
0.00
estimate
—
5
78
19
102
2.04
1.90
16.1
6.0
103.63
103.89
mmol/l
0.07
19
102
26
395
0.55
1.86
5.7
3.8
0.00
0.05
estimate
—
5
73
9
175
0.47
1.44
5.3
2.8
0.98
0.85
ug/l
—
9
124
26
369
0.62
1.34
4.4
4.3
106.32
57.11
ng/l
0.35
19
284
17
262
0.59
1.20
1.8
1.8
19.09
18.55
nmol/l
0.07
17
216
0
33
0.00
1.18
0.0
1.8
—
2.83
—
0
28
14
226
0.57
1.17
7.0
3.9
0.00
0.00
estimate
—
5
68
0
35
0.00
1.17
0.0
1.0
—
—
—
0
0
8
40
2.08
1.14
23.5
9.2
27.00
23.87
mmol/l
—
8
40
0
29
0.00
0.99
0.0
1.4
—
38.61
—
0
23
5
105
0.45
0.94
4.4
5.3
33.00
32.99
%
—
5
72
13
81
1.68
0.85
15.8
7.0
116.54
123.15
g/l
0.55
13
81
8
47
1.76
0.82
1.5
1.5
—
—
—
0
0
7
43
1.67
0.68
2.3
2.2
8.63
14.63
nmol/l
—
7
37
0
20
0.00
0.61
0.0
1.9
—
3.24
—
0
15
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
7
45
1.59
0.50
4.0
3.5
24.64
23.72
mmol/l
—
7
45
13
174
0.71
0.48
4.3
3.8
26.23
344.47
ng/l
1.31
13
143
5
85
0.57
0.47
1.2
1.3
—
—
—
0
0
8
56
1.46
0.44
1.8
1.6
—
—
—
0
0
7
101
0.67
0.42
11.3
8.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
21
171
1.28
0.39
3.6
1.9
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
23
274
0.80
0.38
4.7
3.0
—
—
—
0
0
10
76
1.35
0.29
2.1
2.3
23.10
7.72
umol/l
—
10
66
29
324
0.86
0.24
3.8
2.4
—
—
estimate
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
0.91
—
0
7
0
12
0.00
0.21
0.0
1.5
—
0.88
—
0
7
0
12
0.00
0.21
0.0
1.5
—
1.14
—
0
7
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
20
227
0.86
0.20
3.9
2.6
28.20
30.94
u/l
0.53
20
212
6
49
1.24
0.20
7.3
2.6
1.12
1.12
%
—
6
49
12
101
1.21
0.17
2.1
1.6
—
—
—
0
0
11
127
0.85
0.13
5.1
2.5
21.64
21.88
%
0.03
11
118
12
107
1.14
0.09
2.2
1.6
—
—
—
0
0
37
353
1.07
0.08
16.6
5.3
1.20
1.20
mmol/l
0.08
37
314
5
64
0.77
0.08
2.2
1.6
1.68
1.79
%
—
5
53
23
245
0.92
0.08
3.4
2.1
65.22
76.26
u/l
0.24
23
225
7
81
0.86
0.07
2.6
3.8
—
—
—
0
0
14
128
1.11
0.07
2.3
1.7
28.22
29.78
s
0.97
14
121
14
149
0.93
0.03
2.1
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
14.60
—
0
5
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
7
69
1.02
-0.00
1.4
2.1
43.86
31.18
u/l
—
7
51
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
43.96
—
0
8
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_RESPIRATORY_INTRATHORACIC3_NAS_WIDE – Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).